Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Pricing of Pharma...

    Pricing of Pharma Products: Dr VK Paul led Standing Committee constituted to recommend prices to NPPA

    Farhat NasimWritten by Farhat Nasim Published On 2019-01-23T10:20:33+05:30  |  Updated On 23 Jan 2019 10:20 AM IST
    Pricing of Pharma Products: Dr VK Paul led Standing Committee constituted to recommend prices to NPPA

    New Delhi: The government recently came up with an order which is likely to clip the powers of drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA). The Department of Pharmaceuticals has constituted a standing committee headed by Niti Aayog to ensure availability of affordable medicines in the market. The committee will be a recommending body to NPPA regarding prices of pharmaceutical products.


    The Standing Committee on Affordable Medicines and Health Products will be headed by NITI Aayog member (health), Dr VK Paul. The seven-member panel includes:




    • Member(Health), NITI Aayog- Chairman

    • Chief economic adviser to Ministry of Finance- Member

    • Secretary of Department of Health Research- Member

    • Vice-chairperson of NLEM- Member

    • Joint Secretary, Department of Industrial Policy and Promotion- Member

    • Director General of Health Services, Ministry of Family Welfare- Member

    • Subject expert in biomedical devices, pharmaceuticals or biotechnology- Invitee Members


    The salient features of the notice are:




    • The Committee shall be housed in the NITI Aayog and will be serviced by it.

    • Where considered necessary, the Committee may interact with the stakeholders like Civil associations of drug manufacturers and individual experts on the subject under reference.

    • The Committee may also co-opt experts from other Government Departments/Ministries/Organizations/Pharma Associations as and when


    The Terms of Reference of the Committee shall be as follows:




    • The Committee shall be a recommending body to NPPA regarding prices of drugs and health

    • The Committee may take a matter for examination, suo-moto or on the recommendations/request of Department of Pharmaceuticals, National Pharmaceutical Pricing Authority and Department of Health & Family Welfare.


    The Committee will meet periodically as needed.


    Till now NPPA was the sole government regulatory agency that controlled the prices of pharmaceutical drugs in India. However, the newly formed standing committee will now intervene and recommend prices of pharmaceuticals products to NPPA.


    The notice can be accessed by clicking on the following link:


    http://pharmaceuticals.gov.in/sites/default/files/Constitution of Standing Committee on Affordable Medicines.pdf


    Also Read: Rs 11000 crore benefit to people from fixing drug prices: Minister

    committeeDepartment of Industrial Policy and Promotiondept of health and Famil WelfareDept of PharmaceuticalsDirector General of Health ServicesDr VK Paulgovt of indiaindian govtMinistry of FinanceNational Pharmaceutical Pricing AuthorityNiti AayogNPPApanelpharm news in indiapharma newspolicy newssecretary of Department of Health Researchstanding committeevice-chairperson of NLEM

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok